Infection in acute exacerbations of chronic bronchitis: A clinical perspective

Respiratory Medicine

Volumn 93, Issue 12, 1999, Pages 845-850

  Read, R C ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAMASE; CHLORAMPHENICOL; DOXYCYCLINE; OXYTETRACYCLINE; SULFAMETHOXAZOLE; TETRACYCLINE; TRIMETHOPRIM;

ADVERSE DRUG REACTION; AGED; CAUSE OF DEATH; CHRONIC BRONCHITIS; DEVELOPED COUNTRY; DISEASE EXACERBATION; DRUG SAFETY; DYSPNEA; ECONOMIC ASPECT; EVIDENCE BASED MEDICINE; HAEMOPHILUS INFLUENZAE TYPE A; HUMAN; LUNG FUNCTION; MALNUTRITION; MORAXELLA CATARRHALIS; MORBIDITY; PRIORITY JOURNAL; REVIEW; SPUTUM; STATISTICAL MODEL; STREPTOCOCCUS PNEUMONIAE; TREATMENT FAILURE;

EID: 0033427798     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0954-6111(99)90048-3     Document Type: Review

References (43)

1. rd ed. Washington DC: US Bureau of the Census; 1991.
2. Thurlbeck WM. Pathophysiology of Chronic Obstructive Pulmonary Disease. Clin Chest Med 1990; 11: 389-403.
3. Meier CF, Jick SS, Derby LE, Vasilakis C, Jick H. Acute Respiratory Tract Infections and Risk of First Time Acute Myocardial Infarction. Lancet 1998; 351: 1467-1471.
4. Read RC, Wilson R, Rutman A, Geoffrey, PK, Cole PJ. Interaction of non-typable Haemophilus influenzae of human respiratory mucosa in vitro. J Infect Dis 1991; 163: 549-558.
5. May JR. The bacteriology of chronic bronchitis. Lancet 1953; 2: 534-537.
6. Bjerkestrand G, Digranes A, Schreiner A. Bacteriological findings in trans-tracheal aspirates from patients with chronic bronchitis and bronchiectasis. Scand J Resp Dis 1975; 56: 201-207.
7. Monso E, Ruiz J, Roselle A, Manterolo J, Fiz J, Morera J, Ausina V. Bacterial infection in chronic obstructive pulmonary disease. Am J Resp Crit Care Med 1995; 152: 131-120.
8. Soler N, Torres A, Ewig S, Gonzales J, Celis R. Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease requiring mechanical ventilation. Am J Resp Crit Care Med 1998; 157: 1498-1505.
9. Groenveld K, Alphen LV, Eijk PP, et al. Endogenous reinfections by Haemophilus influenzae in patients with chronic obstructive pulmonary disease: the effect of antibiotic treatment on persistence. J Infect Dis 1990; 161: 512-517.
10. Read RC, Finch RG. Bacterial infections of the respiratory tract. In: Topley and Wilson's Systemic Microbiology. pp. 319-347. Vol. 3. Eds. Sussman, M., Baylow, G.L. 1998. London: Arnold.
11. Ball P. Epidemiology and treatment of chronic bronchitis and its exacerbations. Chest 1995; 108: 43S-52S.
12. Fagon J-Y, Chastre J, Trouille, J-L, Domart Y, Dombret M-C, Bornet M, Gibert C. Characterisation of distal bronchial microflora during acute exacerbation of chronic bronchitis. Am Rev Resp Dis 1990; 142: 1004-1008.
13. Gump DW, Phillips EA, Forsyth BR, et al. Role of infection in chronic bronchitis. Am Rev Resp Dis 1976; 113: 465-473.
14. Saint S, Bent S, Vittinghoff E, Grady D. Antibiotics in chronic obstructive pulmonary disease exacerbations. JAMA 1995; 273: 957-960.
15. Orn PH, Scherer K, Macdonald A, Moffatt ME. Randomized placebo-controlled trials of antibiotics for acute bronchitis: A critical review of the literature. J Fam Pract 1993; 36: 507-512.
16. Elmes PC, Fletchen CM, Dutton AAC. Prophylactic use of oxytetracycline for exacerbations of chronic bronchitis. Br Med J 1957; 2: 1272-1275.
17. Berry DG, Fry J, Hindley CP, et al. Exacerbations of chronic bronchitis treatment with oxytetracycline. Lancet 1960; 1: 137-139.
18. Fear EC, Edwards G. Antibiotic regimes in chronic bronchitis. Br L Dis Chest 1962; 56: 153-162.
19. Elmes PC, King TKC, Langlands JHM, et al. Value of ampicillin in the hospital treatment of exacerbations of chronic bronchitis. Br Med J 1965; 2: 904-908.
20. Petersen ES, Esmann V, Honcke P, Munknes C. A controlled study of the effect of treatment of chronic bronchitis: an evaluation using pulmonary function tests. Acta Med Scand 1967; 182: 293-301.
21. Pines A, Raafat H, Greenfield JSB, Linsell WD, Solari ME. Antibiotic regimens in moderately ill Patients with purulent exacerbations of chronic bronchitis. Br J Dis Chest 1972; 66: 107-115.
22. Nicotra MB, Rivera M, Awe RJ. Antibiotic therapy of acute exacerbations of chronic bronchitis. Ann Intern Med 1982; 97: 18-21.
23. Anthonisen NR, Manfreda J, Warren CPW, Hershfield ES, Harding GKM, Nelson NA. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987; 106: 196-204.
24. Jorgensen AF, Coolidge J, Pedersen PA, et al. Amoxicillin in treatment of acute uncomplicated exacerbations of chronic bronchitis. Scand J Prim Health Care 1992; 10: 7-11.
25. Dorca J, Torres A. Lower respiratory tract infections in the community: towards a more rational approach. Eur Resp J 1996; 9: 1588-1589.
26. Siafakas NM. On behalf of the ERS. Optimal assessment in management of chronic obstructive pulmonary disease (COPD). Eur Resp J 1995; 8: 1398-1420.
27. American Thoracic Society. Am J Resp Med Crit Care 1995; 152: 77S-120S.
28. The COPD Guidelines Group of the Standards of Care Committee of the BTS. BTS Guidelines for the Management of Chronic Obstructive Pulmonary Disease. Management of acute exacerbations of COPD. Thorax 1997; 52 (Suppl 5): S16-21.
29. Felmingham D, Robbins MI, Tesfaslasie Y, Harding I, Shrimpton S, Grüneberg RN. Antimicrobial susceptibility of community-acquired lower respiratory tract bacterial pathogens isolated in the U.K. during the 1995-1996 cold season. J Antimicrob Chemother 1998; 41: 411-415.
30. Retsema J, Girard A, Schelkley W, et al. Spectrum and mode of action of azithromycin, a new 15-membered ring macrolide with improved potency against Gram-negative organisms. Antimicrob Agents Chemother 1987; 31: 1939-1947.
31. Amyes SGB, Gemmell CG. Antibiotic resistance. J Med Microbiol 1997; 46: 436-470.
32. Pallares L, Linares J, Vadillo M, Cabellos C, Manresa F, Viladrich BF. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain, N Eng J Med 1995; 333: 474-480
33. Friedland IR, McCracken GH, et al. Management of infections caused by antibiotic resistant Streptococcus pneumoniae. N Eng J Med 1994; 331: 377-380.
34. Guillemot D, Carbon C, Balkau B, Geslin P, Lecoeur H, et al. Low dosage and long treatment duration of β-lactam. JAMA 1998; 279: 365-370.
35. Gonzales R, Sande M. What will it take to stop physicians from prescribing antibiotics in acute bronchitis? Lancet 1995; 345: 665-666.
36. Fahey T, Stocks N, Thomas T. Quantitative and systematic review of randomised control trials comparing antibiotic with placebo for acute cough in adults. Brit Med J 1998; 316: 906-910.
37. Anthonisen NR, Wright EC, Hodgkin IE, et al. Prognosis in chronic obstructive pulmonary disease. Am Rev Resp Dis 1986; 133: 14-20.
38. Reid DD, Fairbaim AS. The natural history of chronic bronchitis. Lancet 1958; 2: 1147-1152.
39. Strom K. Survival of patients with chronic obstructive pulmonary disease receiving longterm domiciliary oxygen therapy. Am Rev Resp Dis 1993; 147: 585-591.
40. Seneff MG, Wagner DP, Wagner RP, Zimmerman JE, Knaus WA. Hospital and one-year's survival of patients admitted to intensive care units with acute exacerbations of chronic obstructive pulmonary disease. JAMA 1995; 274: 1852-1857.
41. Prescott E, Lange P, Vestbo J. Chronic mucus hypersecretion in COPD and death from pulmonary infection. Eur Resp J 1995; 8: 1333-1338.
42. Ball P, Harris JM, Lowson D, et al. Acute infective exacerbations of chronic bronchitis. Q J Med 1995; 88: 61-68.
43. Staley H, McDade HP, Poes D. Is an objective assessment of antibiotic therapy in exacerbations of chronic bronchitis possible? J Antimicrob Chemother 1993; 31: 193-197.